Evening routine
Why is CBN called the sleep cannabinoid?
Written by: Author pendingReviewed by: Reviewer pendingUpdated:
Mostly because of marketing built on old, small studies. A 2021 review screened 99 human studies and found only 8 with usable CBN data, most from the 1970s and none using validated sleep measures (Cannabis and Cannabinoid Research). Newer randomized trials of 20 to 100 mg are the first real tests, and their results are mixed.
CBN picked up its nickname decades before anyone ran a proper trial. The reputation came first; the data are only now catching up, and they are less tidy than the label copy.
Where did the sleep reputation come from?
Three sources, none of them a modern trial. The first is chemistry: CBN forms as THC breaks down, so aged cannabis carries more of it, and old folk wisdom held that stale cannabis made people sleepier. Montana's Cannabis Control Division describes CBN as a degradation product of delta-9 THC and notes that users "may report a calming effect that leads to drowsiness," which is why "CBN is typically marketed as a sleep aid."
The second source is a handful of human studies from the 1970s and 1980s, which gave CBN alone or with THC to small groups and recorded subjective drowsiness. The third is the hemp industry's need for a non-intoxicating product with a clear use case after the 2018 Farm Bill. CBN gummies, with their sleep positioning, filled that slot.
What did the evidence review find?
Not much to stand on. A 2021 narrative review in Cannabis and Cannabinoid Research screened 99 human studies and could extract CBN data from only 8. Most were decades old, enrolled few participants with little demographic diversity, and none used validated sleep questionnaires or polysomnography. The author's conclusion was direct: "there is insufficient published evidence to support sleep-related claims," and the review called for randomized trials at doses well above the 5 mg or less typical of products at the time.
What have the randomized trials shown since?
Two placebo-controlled trials, with different results. The first, published in Experimental and Clinical Psychopharmacology, randomized adults aged 18 to 55 who rated their sleep as poor to placebo, 20 mg of CBN, or 20 mg of CBN plus 10, 20 or 100 mg of CBD for seven nights; the primary analysis included 293 participants. Compared with placebo, 20 mg CBN did not significantly improve overall sleep quality (p = .082) but did reduce nighttime awakenings (p = .025) and overall sleep disturbance (p = .023). Adding CBD did not improve on CBN alone, and no group differed from placebo on time to fall asleep or daytime fatigue.
The second, in Pharmaceuticals, randomized 1,020 participants to placebo, 4 mg of melatonin, or hemp-derived CBN at 25, 50 or 100 mg, measuring sleep disturbance on a validated PROMIS scale. All active groups improved versus placebo, with no significant difference between any CBN dose and melatonin, and side-effect frequency did not differ from placebo. That study was conducted and funded by a company whose employees are among the authors, which the paper discloses.
Read together: one trial found a partial effect at 20 mg, the other found an effect at 25 to 100 mg comparable to a common melatonin dose. Neither used polysomnography, both relied on self-report, and both ran for a short period. That is a real improvement on the 1970s record and still far short of what the 2021 review asked for.
So is the nickname earned?
Partly. CBN now has randomized, placebo-controlled data on sleep measures, which most minor cannabinoids lack. The doses that showed effects, 20 to 100 mg, are several times higher than many early products contained, so a 5 mg gummy is not what the trials tested. The honest label would read "the cannabinoid with two sleep trials," which is less catchy and more accurate. A buyer comparing products should look at the milligrams of CBN per serving against the 20 to 100 mg trial range, and check the certificate of analysis for how the CBN was made, since most retail CBN is converted from CBD rather than extracted from the plant.
This page is general information, not personalized guidance.
General information, not personalized guidance.
Sources
- Cannabinol and Sleep: Separating Fact from Fiction Cannabis and Cannabinoid Research, via PubMed (accessed 2026-10-13)
- Cannabinol: Synthetic or Naturally Derived Montana Department of Revenue, Cannabis Control Division (accessed 2026-10-13)
- A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality Experimental and Clinical Psychopharmacology, via PubMed (accessed 2026-10-13)
- A randomized, double-blind, placebo-controlled trial of melatonin and three TruCBN formulations for improving sleep Pharmaceuticals (Basel), via PubMed (accessed 2026-10-13)
Related questions
What is CBN and how is it made?
CBN (cannabinol) is a minor cannabinoid that forms when THC breaks down with heat, air and time; Montana's cannabis regulator calls it a degradation product of delta-9 THC found...
CBN vs melatonin: how do they differ?
Melatonin is a hormone the brain makes in darkness; CBN is a cannabinoid that forms as THC degrades. Both are sold as supplements, and one randomized trial of 1,020 adults found...
When should I take a sleep gummy before bed?
Earlier than most people do. Swallowed cannabinoids reach peak blood levels about 1 to 4 hours after a dose (Frontiers in Pharmacology), so a gummy taken at lights-out peaks...
What does the research say about CBD and sleep?
Mixed and early. The largest observational dataset, a 2019 chart review of 72 adults taking 25 mg of CBD daily, found sleep scores improved in 66.7 percent within the first month...